Da Cunha, Violette, Davies, Mark R., Douarre, Pierre-Emmanuel, Rosinski-Chupin, Isabelle, Margarit, Immaculada, Spinali, Sebastien, Perkins, Tim, Lechat, Pierre, Dmytruk, Nicolas, Sauvage, Elisabeth, Laurence, Ma, Romi, Benedetta, Tichit, Magali, Lopez-Sanchez, Maria-José, Descorps-Declere, Stéphane, Souche, Erika, Buchrieser, Carmen, Trieu-Cuot, Patrick, Moszer, Ivan, Clermont, Dominique, Maione, Domenico, Bouchier, Christiane, Mcmillan, David J., Parkhill, Julian, Telford, John L., Dougan, Gordan, Walker, Mark J., Holden, Matthew T. G., Poyart, Claire, Glaser, Philippe, Melin, Pierette, Decheva, Antoaneta, Petrunov, Bogdan, Kriz, Paula, Berner, Reinhard, Buchele, Anna, Hufnagel, Markus, Kunze, Mirjam, Creti, Roberta, Baldassarri, Lucilla, Orefici, Graziella, Berardi, Alberto, Granger, Javier Rodriguez, Fraile, Manuel De La Rosa, Afshar, Baharak, Efstratiou, Androulla, Biologie des Bactéries pathogènes à Gram-positif, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, University of Queensland [Brisbane], The Wellcome Trust Sanger Institute [Cambridge], Novartis Vaccines and Diagnostics [Siena], Centre national de Référence des Streptocoques (CNR), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre d'Informatique pour la Biologie, Institut Pasteur [Paris], Génomique (Plate-Forme) - Genomics Platform, Biologie des Bactéries intracellulaires - Biology of Intracellular Bacteria, Collection de l'Institut Pasteur (CIP), QIMR Berghofer Medical Research Institute, Inflammation and Healing Research Cluster, Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Maroochydore DC, QLD 4558, Australia, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), This work was supported by the French National Research Agency (Grant ANR-08-GENM-027-001 and 2010-PATH-004-02) and by the Labex IBEID. The Institut Pasteur Genopole is a member of France Génomique (ANR10-IBNS-09-08). M.R.D. is supported by the National Health and Medical Research Council of Australia (565526 and 635250). M.T.G.H. and J.P. were supported by Wellcome Trust grant 098051. This study was in part supported by the European Commission Seventh Framework (grant agreement number 200481) as part of the DEVANI program. We would like to acknowledge Dr Sri Sriprakash and Ms Karen Taylor for their involvement with the Australian GBS strain collection and Alexandre Almeida for critical reading of the manuscript., ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), European Project: 200481,EC:FP7:HEALTH,FP7-HEALTH-2007-A,DEVANI(2008), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), Lassailly-Bondaz, Anne, Organisation et montée en puissance d'une Infrastructure Nationale de Génomique - - France-Génomique2010 - ANR-10-INBS-0009 - INBS - VALID, Integrative Biology of Emerging Infectious Diseases - - IBEID2010 - ANR-10-LABX-0062 - LABX - VALID, and Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response - DEVANI - - EC:FP7:HEALTH2008-01-01 - 2011-06-30 - 200481 - VALID